Introduction:
Alveolar soft part sarcoma (ASPS) is a rare type of soft tissue sarcoma that mainly affects adolescents. It was first described in 1952 by Christopherson and colleagues. ASPS is characterized by its slow growth, indolent behavior, and histological features.
Read this article to learn the overview of Alveolar soft part sarcoma, including its diagnostic methods, treatment options, and prognosis.
What Are Alveolar Soft Part Sarcomas?
Alveolar soft part sarcoma (ASPS) is a rare cancer that develops in the body's soft tissues, like muscles, fat, or nerves. It usually starts in the legs but can originate in the head, neck, and arms. It grows slowly and can eventually spread to other parts of the body. It often comes back even after treatment, sometimes years later. While it is uncommon in children, it can affect them too.
ASPS does not show symptoms right away due to its slow growth. The exact cause of ASPS is unknown, but genes may play a role. Treatment for ASPS involves surgically removing the tumor, and sometimes radiation therapy is needed. After tumor removal, children will need ongoing follow-up care to monitor for any cancer recurrence.
How Common Is Alveolar Soft Part Sarcoma?
Alveolar soft part sarcoma (ASPS) is a highly uncommon form of cancer. Among all the different types of cancers found in soft tissues, ASPS comprises less than one percent of cases. It mainly affects teenagers and young adults, with the average age of diagnosis being around 25 years.
Females tend to be more affected by ASPS than males. Because ASPS is so rare, it is complex to gather complete information about how often it occurs. Nevertheless, compared to other types of cancers, ASPS is considered to be quite infrequent.
Does Alveolar Soft Part Sarcoma Run In Families?
-
ASPS is generally not inherited and does not run in families predictably. It arises from spontaneous genetic changes in soft tissues.
-
Rarely, ASPS may occur in multiple family members, suggesting a potential genetic predisposition.
-
Specific genetic alterations, like the ASPSCR1-TFE3 fusion gene, play a role but are typically not inherited.
-
Most cases of ASPS are not associated with a family history. Individuals with a personal or family history of ASPS may find genetic counseling beneficial.
How Does Alveolar Soft Part Sarcoma Form?
The exact process of how alveolar soft part sarcoma (ASPS) forms has yet to be fully understood. It is believed to originate from genetic changes in soft connective tissues.
ASPS is often associated with a genetic alteration called the ASPSCR1-TFE3 fusion gene, resulting from a rearrangement of chromosomes 17 and X. These genetic changes lead to uncontrolled cell growth, forming a slow-growing tumor in soft tissues. The cause of these genetic changes is thought to be spontaneous rather than inherited or caused by environmental factors. Further research is needed to understand ASPS formation better.
How To Diagnose Alveolar Soft Part Sarcoma?
In adults, ASPS is commonly discovered as a painless lump in the leg or buttock, although it can also occur in the trunk or arms. However, in children, ASPS is often found in the head and neck, particularly around the tongue or eye socket. Regardless of age, early detection of ASPS can be challenging. To diagnose ASPS, doctors follow these steps:
- Medical History And Physical Examination: The doctor will discuss the patient's symptoms, medical background, and any noticeable changes. A comprehensive physical examination will evaluate the affected region and any related symptoms.
- Imaging Tests: If ASPS is suspected, the doctor will utilize imaging scans like CT (computed tomography) or MRI (magnetic resonance imaging) to examine the tumor's size and location in the body. These scans also help determine if the tumor has spread to other areas.
- Biopsy: A biopsy is performed to confirm ASPS. A small sample is taken from the tumor using a needle during this procedure. A pathologist then examines the sample under a microscope to determine the specific type of tumor.
- Other Tests: Additional tests, such as blood tests, molecular testing, or genetic testing, may be recommended to gather more information about the tumor's characteristics and potential treatment options.
How Is Alveolar Soft Part Sarcoma Treated?
The treatment approach for alveolar soft part sarcoma (ASPS) typically involves a combination of surgical removal of the tumor and adjuvant therapies like radiation therapy. The treatment plan for a specific case may differ based on various factors, including the size and location of the tumor, as well as its potential metastasis to other body parts.
- Surgery: The primary treatment for ASPS is the surgical removal of the tumor. The objective is to eliminate the tumor while removing a portion of surrounding healthy tissue as a precaution to reduce the likelihood of a recurrence. In some cases, surgical removal may be impossible if the tumor is located in a challenging area or has spread extensively.
- Radiation Therapy: Radiation therapy is commonly employed following surgery to eradicate residual cancer cells and minimize the likelihood of cancer recurrence. It involves the targeted delivery of high-energy radiation to the tumor site. Radiation therapy may also be considered the primary treatment in cases where complete surgical removal is impossible.
- Target Therapy: ASPS has shown limited response to conventional chemotherapy drugs. However, in some instances where the tumor has spread or cannot be removed surgically, targeted therapies such as tyrosine kinase inhibitors (TKIs) may be used. TKIs block specific proteins in tumor growth and may help slow disease progression.
- Clinical Trials: Clinical trials evaluating new treatment approaches or drugs may be considered a potential option for individuals diagnosed with ASPS, an uncommon cancer type. These trials help assess the effectiveness of novel therapies and provide access to potentially promising treatments.
Treatment plans are personalized based on individual circumstances, and it is essential to consult with a multidisciplinary team of healthcare professionals experienced in treating sarcomas to determine the most appropriate treatment options. Regular follow-up care is necessary after treatment to monitor for any signs of recurrence or potential long-term effects.
What Is The Prognosis For Someone With Alveolar Soft Part Sarcoma?
The prognosis for alveolar soft part sarcoma (ASPS) can vary based on tumor size, location, stage, and metastasis. ASPS generally has a relatively favorable prognosis compared to more aggressive sarcomas. It is slow-growing and has higher long-term survival rates. However, factors like tumor size, metastasis, response to treatment, and genetic characteristics can influence prognosis. Consulting with a sarcoma specialist is essential for an accurate prognosis. Regular follow-up care is necessary to monitor for recurrence.
Conclusion:
Alveolar soft part sarcoma is an uncommon type of cancer that primarily impacts individuals in their youth and mainly affects the soft tissues. Its distinct histopathological features and unique clinical behavior necessitate accurate diagnosis and appropriate management. While surgical resection continues to be the primary approach for treatment, ongoing studies focusing on targeted therapies provide a promising outlook for enhanced outcomes in the future. Further studies are needed to better understand the underlying biology of ASPS and develop novel treatment strategies to optimize patient outcomes.
